Lab Information
Sasha Bernatsky (MD/PhD)
Senior ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
Pharmacoepidemiology • systemic lupus • rheumatic disease • drug safety and effectiveness • air pollutionResearch Interests
My research focuses mainly on outcomes in rheumatic diseases, pharmacoepidemiology, and air pollution’s effects on health.Team Members
| Name | Position |
|---|
Latest Publications
- Becker, Y. L. C., Boilard, É., Rollet-Labelle, E., Lood, C., Julien, A.-S., Abrahamowicz, M., Allaeys, I., Choi, M., Leclerc, J., Lévesque, T., Urowitz, M., Hanly, J. G., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Clarke, A. E., Bernatsky, S., Wallace, D., Isenberg, D., Rahman, A., Merrill, J., Gladman, D. D., Bruce, I. N., Petri, M., Ginzler, E., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., Alarcόn, G. S., van Vollenhoven, R., Aranow, C., Ruiz-Irastorza, G., Lim, S., Inanc, M., Kalunian, K., Jacobsen, S., Peschken, C., Kamen, D., Askanase, A., Buyon, J. & Fortin, P. R. (2025). Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality. Annals of the rheumatic diseases.
- Moura, C. S., Randall, J. R., Klarenbach, S., Behlouli, H., Luu, H., Amoozegar, F., Kaboré, J.-L. & Bernatsky, S. (2025). Persistence, switching, and healthcare use after initiating calcitonin gene-related peptide inhibitors: a real-world assessment. The journal of headache and pain.
- Garg, S., Blanchet, B., Nguyen, Y., Hollnagel, F., Clarke, A., Petri, M., Urowitz, M. B., Hanly, J. G., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Clarke, A. E., Bernatsky, S., Wallace, D. J., Isenberg, D. A., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Ginzler, E. M., Dooley, M. A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., Alarcón, G. S., Van Vollenhoven, R. F., Aranow, C., Le Guern, V., Mackay, M., Ruiz-Irastorza, G., Lim, S. S., Inanc, M., Kalunian, K. C., Jacobsen, S., Peschken, C. A., Kamen, D. L., Askanase, A., Buyon, J., Chezel, J., Puszkiel, A. & Costedoat-Chalumeau, N. (2025). Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring. Arthritis & rheumatology (Hoboken, N.J.).
- Oketola, B., Bernatsky, S., Lukusa, L., Moura, C. S., Neville, A., Leung, Y., Narula, N., Afif, W., Birck, M. G., Zezos, P., Singh, H. & Canadian IBD Research Consortium (2026). Drug Discontinuation and Persistent Symptoms Among Initiators of Bio-Originator and Biosimilar anti-Tumor Necrosis Factor Drugs in Inflammatory Bowel Disease: Real-World Contemporary Data From the CAnadian Network for Advanced Interdisciplinary Methods/CIRC Registry. Gastro hep advances, vol. 5, p. 100821.
- Flatman, L. K., Bernatsky, S., St-Pierre, Y., Beauchamp, M.-E., Malhamé, I., Bérard, A. & Vinet, É. (2025). Serious Infections in Offspring Exposed to Tumour Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability. Arthritis & rheumatology (Hoboken, N.J.).
- Aly, S., Parastandehchehr, G., Bernatsky, S., Vinet, É., Arnaud, L., Costedoat-Chalumeau, N., Fortin, P. R., Reynolds, J. A., Thorne, C., Touma, Z., Wallace, D., Werth, V. P., Singer, W. & Mendel, A. (2025). A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus. The Journal of rheumatology.
- Caricchio, R., Bell, S., Bernatsky, S., Dall'Era, M., Goddard, D., Kalunian, K., Kim, A. H. J., Koumpouras, F., Rubio, J., Saxena, A., Sheikh, S. & Lupus Clinical Investigators Network (2025). A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases. ACR open rheumatology, vol. 7, p. e70139.
- Bérard, A., Sheehy, O., Kaul, P., Eltonsy, S., Walker, M., Hawken, S., Bernatsky, S., Pugliese, M., Barrett, O., Savu, A. & Dragan, R. (2025). COVID-19 Infections Still Occur: How Do Pregnant and Non-Pregnant Individuals Compare? A Study from the Canadian Mother-Child Initiative on Drug Safety in Pregnancy (CAMCCO). International journal of environmental research and public health, vol. 22.
- Moghaddam, S. M., Zhao, N. & Bernatsky, S. (2026). Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus: A Review. Rheumatic diseases clinics of North America, vol. 52, p. 47-64.
- Flatman, L. K., Beauchamp, M.-E., St-Pierre, Y., Malhamé, I., Bérard, A., Bernatsky, S. & Vinet, É. (2025). Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases. ACR open rheumatology, vol. 7, p. e70117.
See also
